Guess which ASX healthcare stock is rocketing 5% today (hint: not ResMed!)

This stock is outpacing the broader sector today.

| More on:
healthcare worker overseeing group of aged care residents at table

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX healthcare stocks are shining today and staging a recovery from the past week's sell-off.

At the time of writing, the S&P/ASX Healthcare Index (ASX: XHJ) is up more than 1% against the benchmark S&P/ASX 200 Index (ASX: XJO)'s 0.5% gain.

Regis Healthcare Ltd (ASX: REG) is an ASX healthcare stock that is on a roll today, surging 5% to fetch $4.36 per share at the time of writing.

Despite no market-sensitive announcements from the company, the stock is one of the top-performing healthcare names at the time of publication on Wednesday, according to CommSec data.

With many focused on health darlings like ResMed Inc (ASX: RMD), you don't want to miss the forest for the trees. There are plenty more names in the healthcare sector.

Let's dive into this lesser-known ASX healthcare stock.

ASX healthcare stock catching a bid

Regis Healthcare is one of Australia's largest aged care providers. The stock is up more than 78% in the past twelve months.

In May, Macquarie analysts rated the ASX healthcare stock a buy. According to my colleague James, the broker cited favourable recommendations from the Aged Care Taskforce as its reasoning.

These recommendations are aimed at supporting a sustainable and innovative aged care system, which bodes well for Regis' future growth, Macquarie says.

The anticipated increase in earnings through 2028 from the industry changes led Macquarie to lift its earnings estimates and set a price target of $5.50 on the ASX healthcare stock.

Financials also a talking point

Regis Healthcare's latest financial results are another talking point, in my opinion. For the first half of FY24, the company reported:

  • Revenue of $480.1 million, up 26% year on year
  • Pre-tax earnings of $52.1 million, a 16% increase compared to the previous period
  • Net profit of $16.3 million, up a staggering 527% from the same period last year

These underlying figures paint a positive picture of growth and profitability.

Whilst it operates in aged care, the ASX healthcare stock's management is rejuvenating the company's balance sheet.

For instance, the company's recent acquisition of CPSM has added five more aged care homes to its books.

This brings its total to 68 residences with 7,604 beds under management. In my view, this expansion has been a significant driver behind the ASX healthcare stock's gain over the past 12 months.

Foolish takeaway

Regis Healthcare is catching a strong bid on Wednesday despite no company-specific news.

With healthcare stocks in general staging a recovery today, it's not unlikely that investors saw an opportunity to buy a high-quality franchise with solid H1 FY24 financials.

It could also be speculation. Who's to truly know?

Past performance is no guarantee of future results, though. As always, conduct your own due diligence and consider chatting to a professional.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »